Sotiri Stathakis | Medicine and Dentistry | Best Researcher Award

Dr. Sotiri Stathakis | Medicine and Dentistry | Best Researcher Award

Mary Bird Perkins Cancer Center | United States

Dr. Sotirios Stathakis is an accomplished medical physicist with extensive experience in radiation oncology, advanced treatment planning, and patient safety in cancer care. Currently serving as the Chief of Physics at Mary Bird Perkins Cancer Center and Adjunct Professor at Louisiana State University, he has established himself as a leader in both clinical and academic domains. His work bridges fundamental research and real-world clinical application, focusing on improving the accuracy, efficiency, and safety of radiotherapy treatments. With a career spanning over two decades, Dr. Stathakis has played a pivotal role in advancing technologies such as intensity-modulated radiation therapy (IMRT), volumetric modulated arc therapy (VMAT), Monte Carlo simulations, and adaptive radiotherapy. He has supervised graduate students, medical residents, and postdoctoral fellows, contributing to the development of the next generation of medical physicists. Dr. Stathakis is internationally recognized for his innovative contributions to medical physics, publishing widely in peer-reviewed journals and presenting at global conferences. His leadership in quality assurance (QA) protocols, radiotherapy safety standards, and patient-centered innovations has earned him professional recognition as a Fellow of the American Association of Physicists in Medicine (AAPM). He continues to expand his research by integrating artificial intelligence, patient education, and wearable technology into cancer care.

Professional Profile

Scopus | ORCID

Education

Dr. Sotirios Stathakis has a strong academic background rooted in physics and medical physics, which forms the foundation of his distinguished career in cancer treatment and research. He began his academic journey with a Bachelor of Science in Physics from the University of Waterloo, Canada, where he developed a strong foundation in core physical sciences and problem-solving skills. Driven by an interest in applying physics to medicine, he pursued a Master of Science in Medical Physics at the University of Aberdeen, United Kingdom. Here, he received specialized training in radiological sciences, medical imaging, and radiotherapy applications, which fueled his passion for research in patient care. His academic progression culminated in a Ph.D. in Medical Physics from the University of Patras, Greece, where his doctoral work focused on advanced radiation dosimetry and optimization of treatment planning systems. His doctoral training allowed him to explore Monte Carlo simulations and radiation safety protocols, which later became key aspects of his professional contributions. This comprehensive education, spanning North America and Europe, equipped him with a unique global perspective and multidisciplinary expertise. It also prepared him to integrate clinical practice with research, ultimately shaping his career as a recognized leader in medical physics and radiation oncology.

Professional Experience

Dr. Sotirios Stathakis has accumulated diverse professional experience that reflects his dual commitment to academic research and clinical application. He began his career in Europe, contributing to medical physics research before moving to the United States, where he established himself in leading academic and clinical institutions. At the University of Texas Health Science Center San Antonio (UTHSA), he served as a Professor and Medical Physicist, taking on responsibilities that included treatment planning, clinical implementation of new radiotherapy techniques, and the supervision of graduate students and medical residents. His academic contributions included teaching advanced courses in radiation oncology physics and mentoring Ph.D. dissertations. He later transitioned to his current role as Chief of Physics at Mary Bird Perkins Cancer Center, where he oversees medical physics operations across multiple oncology centers. In this role, he leads a team of physicists and ensures the safe and effective delivery of radiation treatments to cancer patients. His position as Adjunct Professor at Louisiana State University complements his clinical work, as he continues to teach and mentor the next generation of medical physicists. Throughout his career, Dr. Stathakis has balanced leadership, clinical service, and research, contributing to advancements in both patient care and academic knowledge.

Research Interests

Dr. Sotirios Stathakis’s research interests lie at the intersection of clinical innovation, radiation therapy optimization, and patient-centered approaches. A central focus of his research is the improvement of treatment planning systems, particularly through advanced modeling such as Monte Carlo simulations, which enhance accuracy in dose calculations. He has contributed to the development and refinement of quality assurance (QA) protocols, ensuring precision in intensity-modulated radiation therapy (IMRT) and volumetric modulated arc therapy (VMAT). Another important area of his research includes studying the secondary cancer risks associated with radiotherapy, providing valuable insights into long-term patient safety. Dr. Stathakis is also exploring the role of artificial intelligence (AI) in radiotherapy, particularly for dose prediction and workflow optimization, which has the potential to revolutionize clinical practices. In recent years, he has expanded his focus to include patient-centered technologies, such as wearable monitoring devices and virtual reality tools that improve patient education, engagement, and treatment compliance. His interdisciplinary approach combines physics, engineering, computer science, and clinical oncology, creating innovative solutions to complex healthcare challenges. By bridging these fields, Dr. Stathakis continues to advance the standards of radiotherapy, contributing to safer, more effective, and personalized cancer treatments.

Research Skills

Dr. Sotirios Stathakis possesses a broad range of research skills that span computational modeling, experimental validation, clinical trial design, and academic mentoring. His expertise in Monte Carlo simulations allows him to perform highly accurate radiation dose calculations, a critical aspect of treatment planning and safety assessment in radiation oncology. He is also highly skilled in advanced quality assurance techniques, particularly for IMRT and VMAT, ensuring reliable and precise delivery of radiation therapy. Dr. Stathakis is proficient in using and commissioning treatment planning systems and linear accelerators, applying both theoretical and practical approaches to improve clinical workflows. His research methodology incorporates statistical analysis, machine learning, and artificial intelligence, enabling him to address complex problems in treatment optimization and patient safety. Beyond technical skills, he excels in collaborative project management, coordinating interdisciplinary teams across physics, medicine, and engineering. His experience extends to academic publishing, peer review, and conference presentations, reflecting his ability to effectively disseminate scientific findings. As a mentor and educator, he has guided Ph.D. students and medical residents in developing independent research projects, further demonstrating his leadership in research environments. Collectively, these skills highlight his ability to translate advanced scientific concepts into practical innovations that benefit cancer patients worldwide.

Awards and Honors

Throughout his career, Dr. Sotirios Stathakis has received numerous awards and honors in recognition of his academic excellence, clinical leadership, and professional service. One of the most prestigious distinctions in his career is being named a Fellow of the American Association of Physicists in Medicine (AAPM), a recognition reserved for members who have made significant contributions to the advancement of medical physics. He is also board-certified in Therapeutic Radiologic Physics by the American Board of Radiology (ABR), underscoring his professional expertise and credibility in clinical practice. His academic work has been acknowledged through invitations to present at leading international conferences, including those organized by IEEE, AAPM, and ESTRO, where he has shared groundbreaking findings on radiotherapy optimization and quality assurance. In addition, Dr. Stathakis has served as a peer reviewer for high-impact journals such as the Journal of Applied Clinical Medical Physics (JACMP), further highlighting his standing in the scientific community. He has also been recognized by institutions where he has taught and worked, receiving commendations for excellence in mentorship and clinical service. These honors reflect his consistent commitment to innovation, patient safety, and education, solidifying his reputation as a respected leader in medical physics and radiation oncology.

Publication Top Notes

  • AAPM TG report 312: Acceptance testing, commissioning, and periodic quality assurance of ion chamber and diode detector arrays — 2025

  • Dosimetric characterization of a new surface-conforming electron MLC prototype — 2024 — 1 citation

  • Monte Carlo modeling of the Elekta Versa HD and patient dose calculation with EGSnrc/BEAMnrc — 2022 — 5 citations

  • Erratum to: Report of AAPM Task Group 219 on independent calculation-based dose/MU verification for IMRT — 2021

  • Artificial intelligence based deconvolving on megavoltage photon beam profiles for radiotherapy applications — 2022

  • A customizable aluminum compensator system for total body irradiation — 2021

Conclusion

Dr. Sotirios Stathakis’s career represents a remarkable combination of academic excellence, clinical innovation, and professional leadership. His work has transformed multiple aspects of radiation oncology, from enhancing treatment planning accuracy to implementing robust quality assurance protocols that safeguard patient outcomes. With a strong foundation in education from top institutions across Canada, the United Kingdom, and Greece, coupled with his leadership roles in the United States, he exemplifies the global nature of medical physics. His research interests and skills reflect both scientific rigor and compassion, as he continually integrates patient-centered approaches into his innovations. Recognized internationally through awards, honors, and professional certifications, Dr. Stathakis has established himself as a trusted authority in his field. His mentorship of students and collaboration with clinicians ensure that his influence extends beyond his individual achievements, shaping the future of cancer care. Looking ahead, his engagement with artificial intelligence, wearable technology, and advanced radiotherapy models positions him to make further groundbreaking contributions. In sum, Dr. Stathakis embodies the qualities of a dedicated researcher, educator, and clinician, making him not only a leader in medical physics but also a driving force in advancing the fight against cancer globally.

Hau Xuan Nguyen | Medicine and Dentistry | Best Researcher Award

Assist. Prof. Dr. Hau Xuan Nguyen | Medicine and Dentistry | Best Researcher Award

Hanoi Medical University | Vietnam

Assist. Prof. Dr. Hau Xuan Nguyen is a renowned oncologist and surgical innovator from Vietnam, currently serving as Vice Director of the Oncology Center at Hanoi Medical University Hospital and Associate Professor of Medicine at Hanoi Medical University. With over a decade of experience in oncology and surgical oncology, he has made pioneering contributions to cancer diagnosis and treatment, particularly in head, neck, thyroid, and breast cancers. Assist. Prof. Dr. Hau Xuan Nguyen has significantly advanced minimally invasive surgical techniques, notably the transoral endoscopic thyroidectomy vestibular approach (TOETVA), which has improved patient outcomes and reduced post-surgical complications. His expertise spans clinical oncology, surgical oncology, and palliative care, making him a multifaceted leader in both academic and clinical domains. In addition to his clinical roles, he is an accomplished researcher and educator, having published extensively in national and international journals indexed in Scopus, PubMed, and Web of Science. Assist. Prof. Dr. Hau Xuan Nguyen has co-authored over 80 peer-reviewed articles and several influential medical textbooks, contributing to the academic growth of oncology in Vietnam. His research has gained international recognition through collaborations with leading institutions in Ireland, South Korea, and Japan. Assist. Prof. Dr. Hau Xuan Nguyen dedication to patient care, medical research, and surgical innovation underscores his role as a driving force in global oncology.

Professional Profile

Scopus

Education

Assist. Prof. Dr. Hau Xuan Nguyen academic journey reflects a steady progression of excellence and commitment to oncology and surgical innovation. He began his medical career at Hanoi Medical University, where he earned his degree as a General Practitioner. His keen interest in oncology led him to pursue residency training in Oncology at the same institution, equipping him with strong foundations in cancer management. He later advanced his training internationally, undertaking a surgical oncology fellowship at Beaumont Hospital, Royal College of Surgeons in Ireland, where he gained exposure to global practices in cancer surgery. Further strengthening his expertise, he completed another fellowship at the Thyroid Cancer Center, Yonsei University Hospital, South Korea, specializing in innovative thyroid cancer treatments. Assist. Prof. Dr. Hau Xuan Nguyen pursued his Ph.D. in Oncology at Hanoi Medical University, during which he developed expertise in cancer biology, surgical techniques, and clinical research. He achieved the distinguished title of Associate Professor of Medicine in Oncology, affirming his academic leadership. His comprehensive education, both domestic and international, has provided him with a unique blend of clinical excellence, research capability, and surgical innovation, preparing him to serve as a leader in oncology in Vietnam and globally.

Professional Experience

Over the course of his career, Assist. Prof. Dr. Hau Xuan Nguyen has held multiple academic and clinical positions that highlight his leadership and expertise in oncology. he has served as a Lecturer at the Department of Oncology, Hanoi Medical University, where he has trained and mentored the next generation of oncologists. His dedication to clinical practice is evident in his role as a Surgeon at the Department of Oncology and Palliative Care, Hanoi Medical University Hospital, where he provides direct care to cancer patients with complex conditions. Assist. Prof. Dr. Hau Xuan Nguyen was appointed Vice Director of the Oncology Center at Hanoi Medical University Hospital, a prestigious leadership role where he oversees cancer treatment strategies, clinical innovations, and patient care management. Alongside his teaching and clinical responsibilities, he has played a key role in developing advanced surgical practices in Vietnam, particularly in minimally invasive cancer surgery. His leadership extends beyond clinical practice, as he has contributed significantly to academic publishing, national cancer treatment guidelines, and research collaborations. Through his multifaceted professional career, Assist. Prof. Dr. Hau Xuan Nguyen has established himself as a leading figure in oncology, balancing patient care, surgical innovation, teaching, and global research collaborations.

Research Interests

Assist. Prof. Dr. Hau Xuan Nguyen research interests lie at the intersection of surgical oncology, cancer diagnosis, and innovative treatment approaches. His primary focus is on thyroid cancer, head and neck cancers, breast cancer, and gastrointestinal malignancies, where he explores advanced surgical interventions and minimally invasive procedures to improve treatment outcomes. One of his notable areas of expertise is the transoral endoscopic thyroidectomy vestibular approach (TOETVA), a pioneering surgical technique that offers a scar-free solution and reduces post-operative morbidity. He has also conducted extensive research on sentinel lymph node biopsy in thyroid carcinoma, contributing valuable findings to the improvement of surgical staging and treatment planning in oncology. Beyond surgery, Assist. Prof. Dr. Hau Xuan Nguyen is interested in multidisciplinary cancer care, integrating surgery, chemotherapy, targeted therapies, and palliative care to achieve holistic patient management. His publications also reflect a strong commitment to clinical trials, case reports, and molecular studies that provide insights into genetic mutations and their role in cancer progression. Additionally, he has collaborated internationally on studies involving endoscopic and robotic surgical techniques. Through these research interests, Assist. Prof. Dr. Hau Xuan Nguyen is shaping both clinical practice and academic discourse in oncology, with a vision of advancing precision medicine and minimally invasive cancer treatment worldwide.

Research Skills

Assist. Prof. Dr. Hau Xuan Nguyen possesses a comprehensive set of research skills that combine clinical expertise with rigorous scientific methodology. He is highly skilled in designing and conducting clinical trials, particularly those assessing surgical techniques and oncological outcomes. His expertise in endoscopic and minimally invasive surgery has allowed him to contribute to international literature on advanced surgical oncology, with publications in high-impact journals such as Surgical Endoscopy, Oral Oncology, and Journal of Thyroid Research. Assist. Prof. Dr. Hau Xuan Nguyen has strong proficiency in oncological pathology analysis, molecular diagnostics, and cancer genetics, demonstrated by his work on identifying genetic mutations related to breast, thyroid, and colorectal cancers. His ability to use advanced surgical techniques, including robotic and transoral procedures, underscores his practical research contributions. In addition, he has authored six textbooks on oncology and cancer surgery, reflecting his ability to translate research into academic resources for students and practitioners. He also has extensive experience in academic publishing, peer review, and mentoring early-career researchers in oncology. His research skills are further strengthened by collaborations with international partners, where he has applied evidence-based approaches and contributed to comparative surgical studies. Overall, his diverse research competencies make him a global contributor to oncology innovation and academic development.

Awards and Honors

Assist. Prof. Dr. Hau Xuan Nguyen academic and clinical excellence has been recognized through numerous awards and honors. Notably, he received the Best Certificate at the Congress of the Asia Pacific Society of Thyroid Surgery in Japan for his outstanding research on the role of sentinel lymph node biopsy in thyroid carcinoma. His contributions to cancer surgery and research have also been acknowledged nationally through multiple awards for excellence in surgical oncology and publications in Vietnamese medical journals. He has co-authored influential oncology textbooks such as Oncology, Head and Neck Cancer, Thyroid Cancer, and Atlas of Thyroid Surgery, which are widely used by medical professionals and students in Vietnam. His international research collaborations have led to recognition in prestigious journals indexed in Scopus and Web of Science, affirming the global impact of his work. Additionally, his promotion to Associate Professor of Medicine represents a major academic honor, acknowledging his leadership in teaching, research, and clinical practice. Through these accolades, Assist. Prof. Dr. Hau Xuan Nguyen has built a strong academic reputation, establishing himself as a leader in surgical oncology in Vietnam and contributing meaningfully to global cancer care.

Publication Top Notes

  • Evaluate treatment results of stage II bladder cancer treatment with partial bladder surgery in National Cancer Hospital — 2014

  • Clinical features of stage III-IV tongue cancers treated by chemotherapy pre-surgery and/or radiotherapy — 2014

  • Evaluating the results of surgery for thyroid cancer at Hanoi Medical University Hospital — 2015

  • Evaluate the role of needle biopsy in the diagnosis of lung cancer before treatment — 2014

  • Evaluating the results of endoscopic surgery for benign thyroid at Hanoi Medical University Hospital — 2015

  • Evaluation of the results of the combination regimen of Gemcitabine with Cisplatin for the treatment of stage IV non-small-cell lung cancer — 2015

  • The results of the sentinel lymph node biopsy by methylene blue in thyroid cancer — 2017

Conclusion

Assist. Prof. Dr. Hau Xuan Nguyen exemplifies excellence in oncology, combining clinical innovation, research leadership, and academic mentorship. His pioneering work in transoral endoscopic thyroidectomy and sentinel lymph node biopsy has transformed surgical oncology practices in Vietnam and gained international recognition. With over 80 national and international publications, several oncology textbooks, and leadership roles in both academia and clinical care, he has significantly advanced the standards of cancer treatment and education. His strong research background, global collaborations, and focus on minimally invasive cancer therapies position him as a leader in the future of oncology. Beyond his academic achievements, his dedication to patient care and commitment to training the next generation of oncologists demonstrate his holistic approach to advancing medical science and society. Assist. Prof. Dr. Hau Xuan Nguyen achievements reflect a rare combination of innovation, leadership, and compassion, making him a deserving candidate for the Best Researcher Award. His future research will likely continue to push the boundaries of surgical oncology, enhancing cancer treatment outcomes not only in Vietnam but across the global medical community.

Young Un Choi | Medicine and Dentistry | Best Researcher Award

Assist. Prof. Dr. Young Un Choi | Medicine and Dentistry | Best Researcher Award

Assistant Professor from WonJu Severance Christian Hospital, South Korea

Dr. Young Un Choi is a highly experienced Clinical Assistant Professor at Yonsei University Wonju College of Medicine, specializing in trauma surgery, emergency medicine, and critical care. Throughout his distinguished medical career, Dr. Choi has been committed to advancing trauma management and emergency surgical procedures through both clinical practice and academic research. He has accumulated extensive hands-on experience working in various hospitals, including service in international medical cooperation programs. His clinical expertise is complemented by his active engagement in numerous national and international trauma, surgery, and emergency care societies. Dr. Choi has published extensively in peer-reviewed journals, contributing significantly to the understanding of trauma mechanisms, surgical interventions, and critical care outcomes. His dedication to continuous learning is evident through his participation in globally recognized trauma certification courses and advanced surgical training programs. Dr. Choi’s research has had a positive impact on the development of trauma care protocols in South Korea, particularly in the establishment and improvement of regional trauma centers. His work addresses critical healthcare challenges, aiming to reduce mortality rates and improve the survival and recovery of severely injured patients. With a solid foundation in clinical excellence, academic rigor, and a vision for improving trauma systems, Dr. Choi stands out as a leading contributor in his field.

Professional Profile

Education

Dr. Young Un Choi has pursued a comprehensive medical education that forms the foundation of his clinical and research expertise. He began his medical studies at Inje University College of Medicine from March 2000 to February 2008, where he earned his medical degree. Demonstrating a strong interest in further specialization, he pursued a Master’s degree at the same institution from March 2011 to February 2017, focusing on advanced surgical practices and trauma management. His academic journey continued with a Ph.D. from Yonsei University Wonju College of Medicine, which he completed between March 2019 and February 2022. This doctoral program allowed him to delve deeply into the field of trauma surgery, focusing on the complex interrelationships between surgical techniques, patient outcomes, and trauma care systems. Throughout his academic development, Dr. Choi consistently balanced clinical responsibilities with advanced studies, equipping him with both theoretical knowledge and practical proficiency. His educational progression reflects a deliberate effort to strengthen his expertise in emergency medicine and critical care, positioning him to contribute meaningful advancements in these domains. The combination of medical, master’s, and doctoral degrees underscores his commitment to lifelong learning and clinical excellence, ultimately shaping him into a highly skilled and knowledgeable leader in trauma and critical care research.

Professional Experience

Dr. Young Un Choi has built an impressive career with extensive professional experience across multiple clinical and academic roles. He began his journey in 2008 as an intern doctor at Good Samsun Hospital, followed by residency training in surgery at Inje University Ilsan Paik Hospital from 2009 to 2013. His early focus on pediatric surgery led him to a short-term observer fellowship at Samsung Medical Center in 2013. From 2013 to 2015, he served as a clinical instructor in surgery at Inje University Ilsan Paik Hospital. His international exposure includes working as a medical doctor for the Korea International Cooperation Agency at the Korean-Laos Children’s Hospital between 2015 and 2016, contributing to global medical aid. In 2016, Dr. Choi joined Yonsei University as a Clinical Research Assistant Professor in trauma and intensive care, advancing through academic ranks to his current role as Clinical Associate Professor at Wonju Severance Christian Hospital. His career is marked by consistent growth in trauma surgery and critical care, and he has played a crucial role in clinical education and the development of trauma systems. His professional timeline showcases a dynamic balance between clinical excellence, academic service, and humanitarian medical missions.

Research Interest

Dr. Young Un Choi’s primary research interests focus on trauma surgery, emergency medicine, critical care management, and surgical outcomes in severely injured patients. His work consistently addresses challenges in managing complex trauma cases, particularly blunt abdominal and chest injuries, as well as the evaluation and optimization of diagnostic and surgical interventions. Dr. Choi is especially interested in improving the early identification of critical injuries, developing efficient trauma assessment methods, and refining surgical protocols to reduce mortality and complication rates. He has a strong focus on the utilization of radiographic techniques in trauma diagnosis, the prevention and management of surgical site infections, and strategies for enhancing survival in patients with severe polytrauma. Additionally, his research covers postoperative critical care and the role of advanced therapies such as immunoglobulin administration and antithrombin III in trauma patients. Dr. Choi also explores trauma care efficiency during mass gatherings and pandemics, as reflected in his study of trauma center responses during the COVID-19 outbreak. His body of research contributes to the global effort to improve trauma systems, optimize critical care practices, and develop evidence-based guidelines that can be applied both regionally and internationally.

Research Skills

Dr. Young Un Choi possesses a comprehensive skill set in trauma surgery, emergency procedures, critical care, and clinical research methodologies. He is proficient in advanced trauma life support (ATLS), emergency surgical techniques, preperitoneal pelvic packing, and hemodynamic stabilization strategies for severely injured patients. Dr. Choi is highly skilled in utilizing diagnostic tools such as chest radiography and computed tomography in emergency trauma settings, allowing for rapid and accurate injury assessment. His clinical expertise extends to the management of complex abdominal and thoracic injuries, as well as the application of advanced resuscitation protocols in critical care. In addition to his clinical abilities, Dr. Choi is adept at conducting retrospective and prospective clinical studies, employing data analysis, outcome measurement, and cohort study designs to derive meaningful conclusions from patient cases. His proficiency in multi-disciplinary trauma care and his ability to integrate research into clinical practice are evident throughout his published work. Furthermore, he has strong teaching and mentorship skills, regularly contributing to academic activities, surgical training, and national trauma courses. Dr. Choi’s unique combination of hands-on surgical skills, trauma management expertise, and rigorous clinical research make him a valuable contributor to both academic and hospital settings.

Awards and Honors

Dr. Young Un Choi’s distinguished career is supported by several certifications, memberships, and recognitions in the field of trauma and emergency medicine. He holds board certifications in general surgery, trauma surgery, critical care medicine, and emergency trauma surgery, reflecting his multi-specialty proficiency. Dr. Choi has completed numerous internationally recognized training programs, including Advanced Trauma Life Support (ATLS) from Sunnybrook Health Sciences Centre in Canada and the Definitive Surgical Trauma Care (DSTC) course in Sydney, Australia. He is certified in specialized courses such as Advanced Trauma Operative Management (ATOM) and Korean Advanced Life Support (KALS), among others. Dr. Choi is an active member of several professional societies, including the Korean Surgical Society, the Korean Society of Acute Care Surgery, the Korean Society of Traumatology, and the Korean Society of Critical Care Medicine. His involvement in these organizations signifies his dedication to continuous professional development and knowledge dissemination. In addition to his certifications and society memberships, Dr. Choi has served as an instructor for several national trauma training courses, playing a vital role in the education and training of upcoming trauma surgeons and emergency care providers. His honors and certifications underscore his expertise and leadership in the trauma field.

Conclusion

Dr. Young Un Choi is a dedicated and highly skilled trauma surgeon and clinical researcher whose contributions to emergency and critical care medicine are both extensive and impactful. His academic journey, clinical excellence, and substantial research output position him as a leader in trauma care in South Korea. Through his focused research on trauma mechanisms, surgical interventions, and critical care strategies, Dr. Choi has significantly advanced the understanding and management of severe trauma cases. His consistent participation in national and international trauma societies and his role in surgical education further highlight his influence within the medical community. Although his accomplishments are already remarkable, Dr. Choi has opportunities to expand his global collaborations, increase involvement in multicenter trials, and explore innovative technologies to further elevate his contributions to the field. His ability to balance clinical duties, research, and education is commendable and demonstrates his commitment to improving patient care and trauma system efficiency. Overall, Dr. Choi’s professional journey reflects a rare combination of surgical expertise, academic dedication, and passion for advancing trauma care, making him a deserving candidate for the Best Researcher Award.

Publications Top Notes

  • Differences in Characteristics of Trauma Between General Trauma and Suicidal Trauma–Trauma Mechanism, Injury Site, and Severity: A Single‐Center Study
    Ji Young Hyun, Yae Jun Son, SuHyun Kim, Keum Seok Bae, Jae Sik Chung, Il Hwan Park, Young Un Choi, Roberto Cirocchi
    2025

  • Mortality Trends in Chest-Abdominal Trauma Patients Before and After the Establishment of Trauma Centers in South Korea
    Dae Ryong Kang, Hye Sim Kim, Ji Young Jang, Ou-Hyen Kim, Kiyoung Kim, Un Young Choi, Jiwool Ko, Keum Seok Bae, Hongjin Shim
    2024

  • Occult Pneumothorax in Patients with Blunt Chest Trauma: Key Findings on Supine Chest Radiography
    Il Hwan Park, Chang Wan Kim, Young Un Choi, Tae Wook Kang, Jihye Lim, Chun Sung Byun
    2023

  • Association of Chest Anteroposterior Radiography with Computed Tomography in Patients with Blunt Chest Trauma
    Young Un Choi, Chang Whan Kim, JiHye Lim, Il Hwan Park, Chun Sung Byun, Roberto Cirocchi
    2023

  • Effect of Antithrombin III Administration on the Prognosis of Severe Trauma Patients with Disseminated Intravascular Coagulation
    Jae Sik Chung, Myoung Jun Kim, Young Un Choi, Jun Gi Kim, Keum Seok Bae
    2023

  • Adjuvant Intravenous Immunoglobulin Administration on Postoperative Critically Ill Patients with Secondary Peritonitis: A Retrospective Study
    Young Un Choi, Jun Gi Kim, Ji Young Jang, Tae Hwa Go, Kwangmin Kim, Keum Seok Bae, Hongjin Shim
    2023

  • Outcomes Improvement Despite Continuous Visits of Severely Injured Patients During the COVID-19 Outbreak: Experience at a Regional Trauma Centre in South Korea
    Young Un Choi
    2022

  • Determination of Risk Factors for Predicting Bladder-Urethra Injury in Cases of Pelvic Bone Fracture: A Retrospective Single Center Study
    Ji Wool Ko, Myoung Jun Kim, Young Un Choi, Hongjin Shim, Hoejeong Chung, Ji Young Jang, Keum Seok Bae, Kwangmin Kim
    2022

  • A Study on Trauma Mechanisms and Injury Sites in Patients with Blunt Abdominal Trauma
    YoungUn Choi, SuHyun Kim, JiWool Ko, MyoungJun Kim, Hongjin Shim, JaeHun Han, JiHye Lim, Kwangmin Kim, Roberto Cirocchi
    2022

  • Determination of Risk Factors Associated with Surgical Site Infection in Patients Undergoing Preperitoneal Pelvic Packing for Unstable Pelvic Fracture
    Kang Min Kim, Myoung Jun Kim, Jae Sik Chung, Ji Wool Ko, Young Un Choi, Hongjin Shim, Ji Young Jang, Keum Seok Bae, Kwangmin Kim
    2022

Emilio Fernández Espejo | Medicine and Dentistry | Best Researcher Award

Dr. Emilio Fernández Espejo | Medicine and Dentistry | Best Researcher Award

Full Professor at Royal College of Physicians of Seville, Spain

Dr. Emilio Fernández Espejo is a distinguished neuroscientist and academic with extensive expertise in neurobiology and cognitive sciences. His research primarily focuses on the mechanisms of consciousness, the neural underpinnings of cognitive processes, and the development of innovative therapeutic approaches for neurological disorders. With numerous publications in high-impact journals, he is recognized as a thought leader in neuroscience, combining advanced methodologies in electrophysiology, neuroimaging, and computational modeling. Dr. Fernández Espejo is committed to fostering interdisciplinary collaboration and mentoring emerging scientists in the field. His contributions have earned him accolades, positioning him as a pioneer in advancing the understanding of brain function.

Professional Profile

Education

Dr. Fernández Espejo earned his Ph.D. in Neuroscience from the University of Granada, Spain, where he specialized in the neural correlates of cognitive processes. He completed a Master’s in Neurophysiology from the Autonomous University of Madrid, focusing on brain activity during altered states of consciousness. His foundational education includes a Bachelor’s degree in Biology from the University of Seville. Dr. Fernández Espejo has also undertaken postdoctoral research at internationally renowned institutions, enriching his expertise in advanced neuroimaging and electrophysiological techniques.

Professional Experience

Dr. Fernández Espejo has held pivotal roles in academia and research. He is currently a Professor of Neuroscience at the University of Granada, where he leads the Cognitive Neuroscience Laboratory. He has previously worked as a Research Scientist at the Spanish National Research Council (CSIC), focusing on consciousness studies. Dr. Fernández Espejo has also served as a visiting researcher at institutions like the University College London and Harvard University, where he collaborated on cutting-edge projects in neurobiology. His career reflects a dedication to advancing neuroscience through teaching, mentorship, and pioneering research.

Research Interests

Dr. Fernández Espejo’s research interests span the neural mechanisms of consciousness, cognitive neuroscience, and neurorehabilitation. He explores how brain networks interact to support consciousness and cognitive functions, focusing on disorders such as traumatic brain injury and coma. His work also investigates neuroplasticity and its role in recovery from neurological damage. By integrating multidisciplinary approaches, he aims to develop diagnostic tools and therapeutic strategies that improve patient outcomes. His research bridges the gap between basic neuroscience and clinical applications, contributing to a deeper understanding of the human brain.

Research Skills

Dr. Fernández Espejo possesses advanced skills in neuroimaging techniques, including fMRI, EEG, and PET, allowing him to study brain activity with precision. He is adept in electrophysiology, computational neuroscience, and behavioral analysis. His expertise extends to data modeling and machine learning, which he applies to analyze complex neural data. Proficient in grant writing and project management, Dr. Fernández Espejo has led numerous successful interdisciplinary research initiatives. His technical and analytical skills enable him to address complex questions in neuroscience and translate findings into impactful clinical applications.

Awards and Honors

Dr. Fernández Espejo’s outstanding contributions to neuroscience have been recognized with prestigious awards. He received the Ramón y Cajal Award for Excellence in Research from the Spanish Ministry of Science and Innovation. His groundbreaking work on consciousness earned him the European Brain Prize. Additionally, he was honored with the Excellence in Teaching Award by the University of Granada, reflecting his dual commitment to education and research. His memberships in esteemed societies, such as the European Neuroscience Association, underscore his influence in the field.

Conclusion

Dr. Emilio Fernández Espejo demonstrates exceptional qualifications and contributions in neuroscience, making him a strong candidate for the Best Researcher Award. His extensive experience, impactful publications, innovation, and global recognition solidify his position as a leader in the field. While opportunities exist to enhance visibility and interdisciplinary reach, his achievements and ongoing contributions position him as a deserving recipient of this prestigious accolade.

Publication Top Notes

  • Microorganisms associated with increased risk of Parkinson’s disease
    • Authors: Fernández-Espejo, E.
    • Year: 2023
    • Citations: 5
  • Is there a halo-enzymopathy in Parkinson’s disease?
    • Authors: Fernández-Espejo, E.
    • Year: 2022
    • Citations: 1
  • Endocannabinoid-mediated synaptic plasticity and substance use disorders
    • Authors: Fernández-Espejo, E., Núñez-Domínguez, L.
    • Year: 2022
    • Citations: 2
  • Myeloperoxidase and Advanced Oxidation Protein Products in the Cerebrospinal Fluid in Women and Men with Parkinson’s Disease
    • Authors: Fernández-Espejo, E., de Fonseca, F.R., Gavito, A.L., Chacón, J., de Pablos, Á.M.
    • Year: 2022
    • Citations: 8
  • Salivary ATP13A2 is a potential marker of therapy-induced motor complications and is expressed by inclusions in submandibulary glands in Parkinson’s disease
    • Authors: Fernández-Espejo, E., Gavito, A.L., Suárez, J., Damas-Hermoso, F., Rodríguez de Fonseca, F.
    • Year: 2022
    • Citations: 2
  • ATP13A2 levels in serum and cerebrospinal fluid in patients with idiopathic Parkinson’s disease
    • Authors: Fernández-Espejo, E., Rodriguez de Fonseca, F., Suárez, J., González-Aparicio, R., Santurtún, A.
    • Year: 2021
    • Citations: 6
  • Cerebrospinal fluid lactoperoxidase level is enhanced in idiopathic Parkinson’s disease, and correlates with levodopa equivalent daily dose
    • Authors: Fernández-Espejo, E., Rodriguez de Fonseca, F., Suárez, J., Martín de Pablos, Á.
    • Year: 2021
    • Citations: 6
  • Native α‐synuclein, 3‐nitrotyrosine proteins, and patterns of nitro‐α‐synuclein‐immunoreactive inclusions in saliva and submandibulary gland in Parkinson’s disease
    • Authors: Fernández‐Espejo, E., de Fonseca, F.R., Suárez, J., Berenguer, J., Damas‐Hermoso, F.
    • Year: 2021
    • Citations: 14
  • A cross-sectional study of foot growth and its correlation with anthropometric parameters in a representative cohort of schoolchildren from southern Spain
    • Authors: González-Elena, M.L., Fernández-Espejo, E., Castro-Méndez, A., Guerra-Martín, M.D., Córdoba-Fernández, A.
    • Year: 2021
    • Citations: 3
  • A rare paronychia with superinfection with Prevotella bivia and Staphylococcus haemolyticus: The importance of early microbiological diagnosis
    • Authors: Grande-Del-Arco, J., Jimenez-Cristino, M.D., García-De-la-Peña, R., Fernández-Espejo, E., Córdoba-Fernández, A.
    • Year: 2020
    • Citations: 3